<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2095</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>EVALUATION OF SOME QUALITY CONTROL ASSESSMENTS OF FIVE BRANDS OF AMOXICILLIN&#13;
SODIUM CAPSULES&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Osadebe</surname><given-names>P.O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ezealisiji</surname><given-names>K.M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agbo</surname><given-names>M.O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ezeani</surname><given-names>I.C.</given-names></name></contrib></contrib-group><volume/><issue/><fpage>5</fpage><lpage>10</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The weight uniformity, disintegration time, active drug content and bactericidal assays of five brands (A-E) of amoxicillin sodium capsules in Nsukka, Nigeria were evaluated using official methods (BP, 2001). All the five brands passed the disintegration time test with disintegration time range of 240.0-360.0 sec; all the brands passed the weight uniformity test with percentage deviation value range of 1.51-4.27 %. However, only brand D passed the active drug content test with percentage absolute drug content of 103.33%. Brand B has percentage active drug content of 107.39 % which is above the BP and USP specifications. Brands A, C and E failed the active drug content with percentage active drug content of 80.00, 72.00 and 66.67 % respectively. All the brands exhibited comparable bactericidal activity (p__ampersandsignlt;0.05) against Gram positive Staphylococcus aureus and may be used interchangeably.&#13;
</p></abstract><kwd-group><kwd/></kwd-group></article-meta></front></article>
